BACKGROUND: The indications for cochlear implantation (CI) are continually
evolving and, as experience accumulates, the relative contraindications for
CI continue to decrease. However, there is little information regarding CI
in patients who may be considered to be at risk for poor wound healing due
to immunosuppression or intercurrent disease.
OBJECTIVE: To assess and report the complication rates, postoperative cours
e, postimplant rehabilitation, and long-term performance of patients consid
ered at risk due to presumably impaired healing capability. We hypothesized
that these patients had outcomes similar to other implanted patients.
METHODS: This is a retrospective chart review of 277 patients who have rece
ived CI at the University of Miami Ear institute between 1990 and 1999. The
clinical courses of 6 patients on immunosuppressive medications and 7 pati
ents with diseases believed to be associated with poor healing are reported
.
RESULTS: Long-term follow-up (mean, 33 months) showed postoperative complic
ation rates, performance, and rehabilitation compliance that were similar t
o published reports of noncompromised patients.
CONCLUSION: CI of selected patients with potentially reduced healing capabi
lities is safe and effective.